Abstract
A range of amines was reacted with norcantharidin (2) to provide the corresponding norcantharimides (9-43). Treatment of norcantharidin with allylamine afforded the corresponding allyl-norcantharimide (20) which was amenable to epoxidation (mCPBA, 22) and subsequent ring opening (MeOH/H+; 23) or alternatively, osmylation (OSO4/NMO; 24). These simple synthetic modifications of 2 facilitated the development of a novel series of norcantharimides displaying modest to good broad spectrum cytotoxicity against HT29 and SW480 (colorectal carcinoma); MCF-7 (breast adenocarcinoma); A2780 (ovarian carcinoma); H460 (lung carcinoma); A431 (epidermoid carcinoma); DU145 (prostate carcinoma); BE2-C (neuroblastoma); and SJ-G2 (glioblastoma). Analogues possessing a C-10, C-12 or C-14 alkyl chain or a C12 linked bis-norcantharimide displayed the highest levels of cytotoxicity. Crown copyright (c) 2007 Published by Elsevier Ltd. All rights reserved.
Original language | English |
---|---|
Pages (from-to) | 6126-6134 |
Number of pages | 9 |
Journal | Bioorganic & Medicinal Chemistry |
Volume | 15 |
Issue number | 18 |
DOIs | |
Publication status | Published - 15 Sep 2007 |